A First in Human Study to Compare Feasibility of Inertial Cavitation Irrigation to SNI in Root Canal Treatment.
Launched by LUMENDO AG · May 10, 2022
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
Inclusion Criteria:
1. Physical status classification system described was used for patients' recruitment. Healthy patients, who were classified by the American Society of Anaesthesiologists (ASA) as ASA I and II
2. Patients with the age of 18 and over
3. Patients who were diagnosed as in need of non-surgical orthograde root canal treatment of an asymptomatic tooth
4. Tooth without signs of previously initiated Root Canal Therapy
Exclusion Criteria:
1. Pregnant and lactating females
2. Patients with chronic periodontal diseases
3. Patients with sensitivity or adverse reactions to any med...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Physical status classification system described was used for patients' recruitment. Healthy patients, who were classified by the American Society of Anaesthesiologists (ASA) as ASA I and II
- • 2. Patients with the age of 18 and over
- • 3. Patients who were diagnosed as in need of non-surgical orthograde root canal treatment of an asymptomatic tooth
- • 4. Tooth without signs of previously initiated Root Canal Therapy
- Exclusion Criteria:
- • 1. Pregnant and lactating females
- • 2. Patients with chronic periodontal diseases
- • 3. Patients with sensitivity or adverse reactions to any medication or materials that were used throughout the treatment procedure
- • 4. Patients with acute periapical periodontitis
- • 5. Patients with acute periodontal abscess
- • 6. Patients who could not abide by the follow-up time
- • 7. Patients who used analgesics 1-week prior or antibiotics 1-month prior to treatment
- • 8. Uncooperative patients
- • 9. Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth)
- • 10. Teeth with poor prognosis, for example, due to deep root caries or big root resorption
- • 11. Teeth with more than/or equal 4 mm periodontal pocket depth
- • 12. Teeth with an inaccessible root end
- • 13. Teeth with apical resorption or a radiologically not clearly defined apex
- • 14. Fractured teeth
- • 15. Teeth with immature or open apices
- • 16. Teeth with root apices extending into the maxillary sinus
- • 17. Teeth with external resorption communicating with the pulp
About Lumendo Ag
Lumendo AG is a pioneering biotechnology company dedicated to advancing innovative therapeutic solutions in the field of minimally invasive procedures. With a strong focus on developing cutting-edge technologies, Lumendo AG aims to enhance patient outcomes through its proprietary platforms that integrate advanced imaging and precision delivery systems. Committed to rigorous research and development, the company collaborates with leading medical institutions and experts to bring transformative treatments to market, ultimately improving the quality of care in various medical specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Unkapanı, Fatih, Turkey
Patients applied
Trial Officials
Tan Firat EYÜBOĞLU, DDS, MDS
Principal Investigator
İstanbul Medipol University, Department of Endodontics, İstanbul/Türkiye
Mutlu ÖZCAN, DDS, MDS
Study Director
İstanbul Medipol University, Istanbul Turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials